Sweden
· Delayed Price · Currency is SEK Vitrolife AB Statistics
Total Valuation
Vitrolife AB has a market cap or net worth of SEK 19.54 billion. The enterprise value is 20.44 billion.
| Market Cap | 19.54B |
| Enterprise Value | 20.44B |
Important Dates
The next estimated earnings date is Thursday, July 17, 2025.
| Earnings Date | Jul 17, 2025 |
| Ex-Dividend Date | Apr 30, 2025 |
Share Statistics
Vitrolife AB has 135.42 million shares outstanding. The number of shares has increased by 0.10% in one year.
| Current Share Class | 135.42M |
| Shares Outstanding | 135.42M |
| Shares Change (YoY) | +0.10% |
| Shares Change (QoQ) | -0.21% |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 64.55% |
| Float | 75.04M |
Valuation Ratios
The trailing PE ratio is 39.32 and the forward PE ratio is 35.00. Vitrolife AB's PEG ratio is 2.57.
| PE Ratio | 39.32 |
| Forward PE | 35.00 |
| PS Ratio | 5.41 |
| PB Ratio | 1.49 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 28.53 |
| P/OCF Ratio | 25.12 |
| PEG Ratio | 2.57 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.02, with an EV/FCF ratio of 29.84.
| EV / Earnings | 41.05 |
| EV / Sales | 5.66 |
| EV / EBITDA | 17.02 |
| EV / EBIT | 26.41 |
| EV / FCF | 29.84 |
Financial Position
The company has a current ratio of 3.77, with a Debt / Equity ratio of 0.15.
| Current Ratio | 3.77 |
| Quick Ratio | 2.98 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 1.62 |
| Debt / FCF | 2.85 |
| Interest Coverage | 8.41 |
Financial Efficiency
Return on equity (ROE) is 3.78% and return on invested capital (ROIC) is 3.18%.
| Return on Equity (ROE) | 3.78% |
| Return on Assets (ROA) | 2.89% |
| Return on Invested Capital (ROIC) | 3.18% |
| Return on Capital Employed (ROCE) | 4.83% |
| Revenue Per Employee | 3.14M |
| Profits Per Employee | 433,043 |
| Employee Count | 1,169 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 3.64 |
Taxes
In the past 12 months, Vitrolife AB has paid 173.00 million in taxes.
| Income Tax | 173.00M |
| Effective Tax Rate | 25.78% |
Stock Price Statistics
The stock price has decreased by -15.46% in the last 52 weeks. The beta is 1.79, so Vitrolife AB's price volatility has been higher than the market average.
| Beta (5Y) | 1.79 |
| 52-Week Price Change | -15.46% |
| 50-Day Moving Average | 149.92 |
| 200-Day Moving Average | 195.60 |
| Relative Strength Index (RSI) | 48.40 |
| Average Volume (20 Days) | 158,110 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vitrolife AB had revenue of SEK 3.61 billion and earned 498.00 million in profits. Earnings per share was 3.67.
| Revenue | 3.61B |
| Gross Profit | 2.14B |
| Operating Income | 774.00M |
| Pretax Income | 671.00M |
| Net Income | 498.00M |
| EBITDA | 1.15B |
| EBIT | 774.00M |
| Earnings Per Share (EPS) | 3.67 |
Balance Sheet
The company has 1.05 billion in cash and 1.95 billion in debt, giving a net cash position of -897.00 million or -6.62 per share.
| Cash & Cash Equivalents | 1.05B |
| Total Debt | 1.95B |
| Net Cash | -897.00M |
| Net Cash Per Share | -6.62 |
| Equity (Book Value) | 13.13B |
| Book Value Per Share | 96.92 |
| Working Capital | 1.67B |
Cash Flow
In the last 12 months, operating cash flow was 778.00 million and capital expenditures -93.00 million, giving a free cash flow of 685.00 million.
| Operating Cash Flow | 778.00M |
| Capital Expenditures | -93.00M |
| Free Cash Flow | 685.00M |
| FCF Per Share | 5.06 |
Margins
Gross margin is 59.34%, with operating and profit margins of 21.44% and 13.80%.
| Gross Margin | 59.34% |
| Operating Margin | 21.44% |
| Pretax Margin | 18.59% |
| Profit Margin | 13.80% |
| EBITDA Margin | 31.91% |
| EBIT Margin | 21.44% |
| FCF Margin | 18.98% |
Dividends & Yields
This stock pays an annual dividend of 1.10, which amounts to a dividend yield of 0.76%.
| Dividend Per Share | 1.10 |
| Dividend Yield | 0.76% |
| Dividend Growth (YoY) | 10.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 27.11% |
| Buyback Yield | -0.10% |
| Shareholder Yield | 0.67% |
| Earnings Yield | 2.55% |
| FCF Yield | 3.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 17, 2018. It was a forward split with a ratio of 5.
| Last Split Date | May 17, 2018 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
Vitrolife AB has an Altman Z-Score of 5.17 and a Piotroski F-Score of 8.
| Altman Z-Score | 5.17 |
| Piotroski F-Score | 8 |